跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Doprina - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Doprina
Approved
STANDARD
Doprina
Myungmoon Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a717f39cc6d3f1c9
Company
Myungmoon Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
a717f39cc6d3f1c9
Drug Approval Philippines Name
Doprina
Product Name
Doprina
Registration Number
DRP-4717
Brand Name
Doprina
Generic Name
Dopamine Hydrochloride
Dosage Form
Solution For Injection (Iv Infusion)
Dosage Strength
40mg/mL (200mg/5mL)
Manufacturer
Myungmoon Pharmaceutical Co., Ltd.
Importer
H&B Pharma International Inc.
Distributor
ELLEBASY MEDICALE TRADING
Issuance Date
29 May 2023
Expiry Date
17 September 2028
Pharmacologic Category
Adrenergic Agents
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a717f39cc6d3f1c9
Type
Standard
Back to Philippines FDA Approvals